MedPath

A strategy game supporting goal management training intervention for the treatment of executive problems after acquired brain injury: A randomized controlled pilot study for usability and preliminary efficacy

Recruiting
Conditions
brain damage
10042258
Acquired brain injury
iet-aangeboren hersenletsel
Registration Number
NL-OMON52362
Lead Sponsor
Revalidatiecentrum Groot Klimmendaal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Age: 18-70
Non-progressive acquired brain injury
Minimal time post-onset of 3 months
Outpatient rehabilitation
Living independently at home
Executive problems evidenced by a clinically meaningful (increased) score on
the BRIEF-A

Exclusion Criteria

Inability to speak/understand the Dutch language
Severe psychiatric problems (history)
Neurodegenerative disorders
Substance abuse
Severe cognitive comorbidity (i.e. dementia)
Aphasia
Neglect
No access to a smartphone, and laptop or tablet
Unable to look at a computer screen for 15 minutes a day
Unable to operate a keyboard and/or computer mouse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameters are to explore the usability and playability of the<br /><br>strategy game, and to assess the feasibility of the<br /><br>shortened GMT treatment. Participants have to complete the system usability<br /><br>scale (SUS) questionnaire at the end of treatment.<br /><br>Furthermore, interviews with participants will be carried out to validate the<br /><br>findings from the survey and to gather participants*<br /><br>experience of using the game, the playability and factors that may affect their<br /><br>treatment outcome. In addition, a questionnaire survey<br /><br>to investigate therapists* acceptance and intention to use the treatment for<br /><br>acquired brain injury cognitive rehabilitation will be<br /><br>conducted in order to assess the feasibility.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study parameters are a standardized scale measuring performance of<br /><br>four different untrained IADL tasks (two tasks at<br /><br>baseline, two other tasks post-treatment). Also, the achievement of goals set<br /><br>(GAS), participation (USER-P), insight and reported<br /><br>severity of executive problems (BRIEF-A), a neuropsychological assessment<br /><br>regarding executive functioning, and the subjective<br /><br>experience of strategy use in daily life and during the performance of IADL<br /><br>tasks.</p><br>
© Copyright 2025. All Rights Reserved by MedPath